Radiofrequency Most Preferred Technology, While Cryoablation Gains Traction in Cardiac Ablation Technologies Market
Less complex functions and minimal invasive approach make radiofrequency a suitable technology for the development of cardiac ablation devices. Another aspect that increases the suitability of this technology is its low-risk profile and high convenience factors, which increases its adoption.
However, in recent times, cryoablation technology is resonating well with patients, as it causes relatively less pain with an enhanced focus on patient safety.
The relevance of these technologies is further studied in detail in an extensive report published by Fact.MR, which portends that, radiofrequency would account for over 50% of the total share, while the adoption of cryoablation technology would grow at the highest rate in the cardiac ablation technologies market.
Minimal Invasion to Remain Key Aspect for Market Players to Focus On
There has been a shift in approach in the way medical professionals carry out surgeries. Patients are demanding shorter hospital stays and minimal post-surgical cramps to get back to normality as soon as possible.
This has encouraged manufacturers to make consistent efforts towards utilising advanced technology to reach the internal organs through small incisions, and relatively low blood loss to achieve better recovery time.
Know More Details About the Report
Cardiac Ablation Devices Subject to Stringent Approval Norms in Developed Regions
Cardiac ablation devices are increasingly used as the first-line of treatment for atrial fibrillation, which demands high safety and efficacy.
Compliance of cardiac ablation systems with regulations set by regulatory authorities, especially in North America and Europe, increases the time-to-market for players in the global cardiac ablation technologies market.
Strict scrutiny of regulatory authorities on product design, development, and clinical trials delays the total time taken for receiving approval and meeting the quality norms of the FDA and CE. This could cause revenue losses for market players, and, in turn, affect the growth of the cardiac ablation technologies market.
Cardiac Ablation Technologies Market to Record Substantial Growth in North America
The U.S. is expected to account for around 37% of the global cardiac ablation technologies market share, as it consists of leading players—Johnson & Johnson, Abbott, and Boston Scientific Corporation.
Easy availability of sophisticated and advanced technology underpins the developmental efforts of these players, which aids them in establishing a diversified product portfolio.
Effective product positioning helps these players in generating revenue from other regions. For instance, cardiac ablation systems manufactured by Abbott are used for the treatment of patients in over 84 countries across the world.
Besides efforts put in by these leading players, demand for cardiac ablation systems is significantly high in the U.S., owing to high number of patients suffering from heart conditions.
Numerous studies have found that cardiac arrest is the leading cause of death in the U.S. This makes the country a key cardiac ablation technologies market, which, in turn, is attributing a pole position to North America.
Avail customized purchase options for your needs
Cardiac Ablation Technologies Market – Assessment of Key Segments
Authors of this comprehensive study have classified the cardiac ablation technologies market into key segments for an in-depth study of the market. Categorisation of the cardiac ablation technologies market is based on treatment type, application, and region. This detailed study also offers information about the incremental opportunity present in the cardiac ablation technologies market during the forecast period. Key segments considered while studying the cardiac ablation technologies market include:
Cardiac Ablation Technologies Market – Scope of the Report
The report on the cardiac ablation technologies market is an exclusive study, which has been recently added to the broad report repository of Fact.MR. The study brings to the fore crucial influencers that have been influencing the growth of the cardiac ablation technologies market.
This comprehensive study offers analytical insights pertaining to the recent developments in the cardiac ablation technologies market, through the analysis of historical data for the period of 2016-2019, while the duration 2020-2026 being considered as the forecast period.
Recalibration of revenue of the cardiac ablation technologies market has been carried out in terms of value (US$ Mn). This research report offers exclusive insights into the influential trends that hold high potential to shape the cardiac ablation technologies market during the forecast period.
Besides this, the report also includes numerous macroeconomic and microeconomic growth indicators that support the growth of the cardiac ablation technologies market during the forecast period. This detailed guide offers crucial information into key dynamics, along with their influence on the cardiac ablation technologies market during the forecast period.
The detailed report, in turn, brings to the fore, insightful information about key challenges and threats that could limit the growth potential of players in the cardiac ablation technologies market.
The study unveils profitable opportunities for manufacturers, which they can adopt to strengthen their position in the global cardiac ablation technologies market. With a view to aid stakeholders in the cardiac ablation technologies market, the study comprises a detailed section on the competition analysis.
This exclusive study offers a dashboard view of the cardiac ablation technologies market, with detailed information about market players, based on overall revenue, key developments, and their market presence.
Additionally, key strategies of players in the cardiac ablation technologies market have also been included in this comprehensive study.
Analysts of the report have analysed the profiles of leading, prominent, and emerging players in the cardiac ablation technologies market, in order to obtain a detailed idea regarding the competition prevailing in the landscape.
Key players profiled in this comprehensive study include Hansen Medical, Inc., Biosense Webster, Inc., MicroPort Scientific Corporation, Boston Scientific Corporation, CardioFocus, Inc., Medtronic PLC, and Abbott.
Cardiac Ablation Technologies Market – Research Methodologies
The primary objective of this exclusive study on the cardiac ablation technologies market is to offer precise estimates and forecasts of the market in terms of value (US$ Mn) for the period of 2020-2026. Secondary objective includes analysis of key market segments exhibiting significant growth rates, leading strategies adopted by players in the cardiac ablation technologies market, and the adoption rate of cardiac ablation technologies in key regions across the world.
Top-down and bottom-up approaches have also been adopted by research analysts in order to validate data and statistics to offer accurate market information to stakeholders.
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.